What is clinically relevant? [Design Issues]

posted by bebac_fan – US, 2018-04-06 22:53 (2203 d 17:57 ago) – Posting: # 18648
Views: 5,404

Dear Helmut:

I believe the spaghetti plots you posted are actually indicative of a infusion of unbound drug.

Release of the encapsulated form follows first order kinetics and is Sequential - kind of like metabolic clearance from parent --> metabolite.

Luckily, you also posted the parent/metabolite curve for doxorubinol. Because of similarity in process, if no free drug is infused, bound and unbound PK should follow the same general shape we see in parent + metabolite.

The fact that total + free dox concentrations are colinear is pretty strong evidence for co-infusion of bound + unbound. Further, the fact that there isn't a lag time in unbound, as well as a nonlinear shape, is evidence, too.

Thanks,
BF

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,667 registered users;
64 visitors (0 registered, 64 guests [including 4 identified bots]).
Forum time: 16:51 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5